ReviewLeukemia2012
Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR-ABL inhibitors as first-line therapy.
P J Shami et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papertrialcites it